Universita’ Degli Studi G. D’Annunzio Di Chieti

Psychiatry and Treatment-Resistant Depression

Clinical research activity includes interventions for treatment-resistant depression, with interest in advanced approaches for patients who do not respond adequately to standard antidepressant care.

  • Psilocybin
  • Personalized rTMS (repetitive transcranial magnetic stimulation)

The sponsor’s work in this area is centered on neuropsychiatric treatment strategies and symptom relief in resistant mood disorders.

Vascular Medicine and Deep Vein Thrombosis

Research also addresses proximal lower-extremity deep vein thrombosis, with a focus on complications that follow venous thromboembolic disease.

  • Post-thrombotic syndrome
  • Inflammation after venous thrombosis

This area reflects interest in reducing long-term vascular sequelae and improving outcomes after thrombotic events.

Inflammation and Anti-inflammatory Therapeutics

The sponsor funds studies examining anti-inflammatory treatment strategies in the context of venous disease, with particular attention to inflammatory pathways linked to clot-related complications.

  • Colchicine
  • Venous thromboembolism-related inflammation

These investigations connect inflammation control with prevention of chronic post-thrombotic complications.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

    Recruiting

    Italy
  • A study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis.

    Not yet recruiting

    1 1
    Investigated drugs:
    Italy